Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Pine Bark Extract wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
0 of 1 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
11 of 14 studies with measurable effects showed benefit.
Top outcomes
300-600mg extract (2.5% ursolic acid)
Morning, With or without food
Standardized extract (leaf)
100-200mg daily
Morning with food, Can be divided into two doses
Pycnogenol (standardized extract)
2-4 weeks
2-4 weeks
4-8 weeks
4-8 weeks
6-12 weeks
4-8 weeks
Initial use
The Neuroprotective Potential of Ocimum Plant Species: Seasoning the Mind with Sweet and Holy Basil
Nutrients (2025) · Systematic review
This review synthesizes experimental evidence regarding Ocimum species with neuroprotective potential in AD, particularly Ocimum sanctum and Ocimum basilicum.
Modulation of the hypothalamic-pituitary-adrenal (HPA) axis by plants and phytonutrients: a systematic review of human trials
Nutritional neuroscience (2022) · Systematic review
For most phytonutrients, the effects of supplementation on HPA-axis activity in humans is unclear.
Medicinal Plants in the Treatment of Respiratory Diseases and their Future Aspects
Recent patents on biotechnology (2025) · Systematic review
Some medicinal plants, notably Echinacea purpurea and Zingiber officinale, exhibit potential for adjuvant symptomatic therapy in respiratory conditions, such as chronic obstructive pulmonary disease (COPD), bronchitis, asthma, the common cold, cough, and whooping cough.
Phlebotonics for venous insufficiency
The Cochrane database of systematic reviews (2020) · Meta analysis · n=7690
Pooled data suggest that phlebotonics probably increase adverse events slightly, compared to placebo (RR 1.14, 95% CI 1.02 to 1.27; 37 studies; 5789 participants; moderate-certainty evidence).
Pine bark (Pinus spp.) extract for treating chronic disorders
The Cochrane database of systematic reviews (2020) · Meta analysis · n=1641
In a mixed group of participants with type 1 and type 2 DM we do not know whether pine bark extract decreases HbA1c (MD -0.20 %, 95% CI -1.83 to 1.43; one study; 67 participants; very low-certainty evidence).
Effect of pycnogenol supplementation on blood pressure: A systematic review and meta-analysis of clinical trials
Phytotherapy research : PTR (2020) · Meta analysis · n=922
Pooled analysis suggested that pycnogenol supplementation can reduced systolic blood pressure (SBP) of (-3.22 mmHg; 95% CI [-5.52, -0.92]) and diastolic blood pressure (DBP; -1.91 mmHg; 95% CI [-3.64, -0.18]).
Based on systematic review evidence of HPA-axis modulation and adaptogenic properties. However, reviewers note that effects on HPA-axis activity in humans remain unclear and require more definitive research. Conservative estimates due to limited human trial data.
Based on meta-analyses showing modest reductions in systolic (-3.22 mmHg) and diastolic (-1.91 mmHg) blood pressure. Effects are clinically small and studies show heterogeneity.
AI-estimated from published studies. Interpret as directional guidance.
Pine Bark Extract has a higher evidence score (9/10 vs 8.5/10) and wins in 1 of 3 categories.
For reduce inflammation, Pine Bark Extract has a higher relevance score (75 vs 65).
No known interactions between Holy Basil and Pine Bark Extract have been documented in our database. However, always consult a healthcare provider before combining supplements.